CA2164933A1 - Methods for Aiding Periodontal Tissue Regeneration - Google Patents

Methods for Aiding Periodontal Tissue Regeneration

Info

Publication number
CA2164933A1
CA2164933A1 CA2164933A CA2164933A CA2164933A1 CA 2164933 A1 CA2164933 A1 CA 2164933A1 CA 2164933 A CA2164933 A CA 2164933A CA 2164933 A CA2164933 A CA 2164933A CA 2164933 A1 CA2164933 A1 CA 2164933A1
Authority
CA
Canada
Prior art keywords
methods
tissue regeneration
periodontal tissue
aiding
aiding periodontal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2164933A
Other languages
French (fr)
Other versions
CA2164933C (en
Inventor
Nalinkant Chunilal Damani
Douglas Charles Mohl
Robert Ernest Singer Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Nalinkant Chunilal Damani
Douglas Charles Mohl
Robert Ernest Singer Jr.
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nalinkant Chunilal Damani, Douglas Charles Mohl, Robert Ernest Singer Jr., The Procter & Gamble Company filed Critical Nalinkant Chunilal Damani
Publication of CA2164933A1 publication Critical patent/CA2164933A1/en
Application granted granted Critical
Publication of CA2164933C publication Critical patent/CA2164933C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont

Abstract

Methods for aiding periodontal tissue regeneration with compositions containing bioresorbable polymers, leachable solvents, and bioavailable drug actives. The compositions useful for these methods are characterized by becoming harder upon contact with the periodontal tissue such that the composition is effective for aiding tissue regeneration and by releasing a therapeutically-effective amount of drug active agent.
CA002164933A 1993-06-11 1994-05-26 Methods for aiding periodontal tissue regeneration Expired - Fee Related CA2164933C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/076,304 US5447725A (en) 1993-06-11 1993-06-11 Methods for aiding periodontal tissue regeneration
US08/076304 1993-06-11

Publications (2)

Publication Number Publication Date
CA2164933A1 true CA2164933A1 (en) 1994-12-22
CA2164933C CA2164933C (en) 1999-01-12

Family

ID=22131142

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002164933A Expired - Fee Related CA2164933C (en) 1993-06-11 1994-05-26 Methods for aiding periodontal tissue regeneration

Country Status (6)

Country Link
US (1) US5447725A (en)
EP (1) EP0702567A1 (en)
JP (1) JPH08511528A (en)
CN (1) CN1126948A (en)
CA (1) CA2164933C (en)
WO (1) WO1994028935A1 (en)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69233022T2 (en) 1991-11-04 2004-02-12 Genetics Institute, LLC, Cambridge RECOMBINANT BONE MORPHOGENETIC PROTEIN HETERODIMERS, COMPOSITIONS AND METHODS OF USE
CA2176942C (en) 1993-12-07 2011-11-01 Anthony J. Celeste Bmp-12, bmp-13 and tendon-inducing compositions thereof
US6027919A (en) * 1993-12-07 2000-02-22 Genetics Institute, Inc. BMP-12 and BMP-13 proteins and DNA encoding them
US20030045943A1 (en) * 1994-05-13 2003-03-06 Brekke John H. Device for regeneration of articular cartilage and other tissue
US8795242B2 (en) * 1994-05-13 2014-08-05 Kensey Nash Corporation Resorbable polymeric device for localized drug delivery
US7963997B2 (en) 2002-07-19 2011-06-21 Kensey Nash Corporation Device for regeneration of articular cartilage and other tissue
US5981825A (en) * 1994-05-13 1999-11-09 Thm Biomedical, Inc. Device and methods for in vivo culturing of diverse tissue cells
US5616315A (en) * 1994-10-13 1997-04-01 Gillette Canada Inc. Particles including degradable material and anti-microbial agent
WO1996013226A1 (en) * 1994-10-31 1996-05-09 Sepracor Inc. Method for the treatment of periodontal disease and a pharmaceutical composition useful in said method
US5660817A (en) 1994-11-09 1997-08-26 Gillette Canada, Inc. Desensitizing teeth with degradable particles
WO1997002019A1 (en) 1995-06-30 1997-01-23 Baylor University Polyester/carboxylic acid composite materials
US5727945A (en) * 1996-08-26 1998-03-17 Dannenbaum; Richard M. Impregnated barrier and method of assisting bone or tissue regeneration
WO1998020842A2 (en) * 1996-11-12 1998-05-22 The Procter & Gamble Company Polymyxin compositions and methods for the treatment of periodontal disease and breath malodor
US6331311B1 (en) 1996-12-20 2001-12-18 Alza Corporation Injectable depot gel composition and method of preparing the composition
US6251419B1 (en) * 1997-04-22 2001-06-26 Hans Georg Graber Membrane system for controlled tissue regeneration in cases of diseases of the periodontium
US6221341B1 (en) * 1997-11-19 2001-04-24 Oraceutical Llc Tooth whitening compositions
US6136341A (en) * 1998-02-27 2000-10-24 Petito; George D. Collagen containing tissue adhesive
ES2359973T3 (en) * 1998-03-19 2011-05-30 MERCK SHARP & DOHME CORP. LIQUID POLYMER COMPOSITIONS FOR THE CONTROLLED RELEASE OF BIOACTIVE SUBSTANCES.
US6602516B1 (en) * 1998-05-05 2003-08-05 Howard Martin Antibiotic/medicated gutta percha point
US6245345B1 (en) 1998-07-07 2001-06-12 Atrix Laboratories, Inc. Filamentous porous films and methods for producing the same
DE19841698A1 (en) * 1998-09-11 2000-03-16 Curative Technologies Gmbh Composition for accelerating healing of tissue damage in cartilage or wounds, comprises thrombocyte growth factor, fibrin or fibrinogen and polymer
ES2224737T3 (en) 1998-12-14 2005-03-01 Osteotech, Inc., BONE GRAFT MADE OF OSE PARTICLES.
US20030228288A1 (en) 1999-10-15 2003-12-11 Scarborough Nelson L. Volume maintaining osteoinductive/osteoconductive compositions
US6579469B1 (en) 1999-10-29 2003-06-17 Closure Medical Corporation Cyanoacrylate solutions containing preservatives
US6461631B1 (en) 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
US20030211974A1 (en) * 2000-03-21 2003-11-13 Brodbeck Kevin J. Gel composition and methods
AU2001249765A1 (en) * 2000-03-30 2001-10-15 Align Technology, Inc. System and method for separating three-dimensional models
EP1299048A4 (en) * 2000-06-28 2005-09-28 Atul J Shukla Biodegradable vehicles and delivery systems of biologically active substances
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US9387094B2 (en) 2000-07-19 2016-07-12 Warsaw Orthopedic, Inc. Osteoimplant and method of making same
US7323193B2 (en) 2001-12-14 2008-01-29 Osteotech, Inc. Method of making demineralized bone particles
US20040077609A1 (en) * 2001-01-16 2004-04-22 Michael Rubin Oral composition containing NSAIDs and essential oils
US7700819B2 (en) 2001-02-16 2010-04-20 Kci Licensing, Inc. Biocompatible wound dressing
US7763769B2 (en) 2001-02-16 2010-07-27 Kci Licensing, Inc. Biocompatible wound dressing
JP2002338480A (en) * 2001-05-17 2002-11-27 Sensho Go Method for producing antispirillar agent pill
TWI267378B (en) * 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
KR20040047746A (en) 2001-10-12 2004-06-05 오스테오테크, 인코포레이티드 Improved bone graft
JP2003171301A (en) * 2001-11-09 2003-06-20 Mahidol Univ Andrographis paniculata gel as adjunct in treatment of periodontitis
DE60232987D1 (en) * 2001-11-14 2009-08-27 Durect Corp INJECTABLE DEPOT COMPOSITIONS
AU2002359407B2 (en) 2001-11-14 2008-02-28 Durect Corporation Catheter injectable depot compositions and uses thereof
JP4202656B2 (en) * 2002-02-19 2008-12-24 サンスター株式会社 Topical sustained-release ointment
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
ES2319400T3 (en) 2002-07-31 2009-05-07 Durect Corporation COMPOSITIONS INJECTABLE DEPOSIT AND USE OF THE SAME.
WO2004011054A2 (en) * 2002-07-31 2004-02-05 Alza Corporation Injectable multimodal polymer depot compositions and uses thereof
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
AU2003279493B2 (en) 2002-10-25 2009-08-20 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US6984128B2 (en) * 2002-11-01 2006-01-10 Bas Medical, Inc. Methods for enabling and stabilizing tooth movement
US20050186526A1 (en) * 2002-11-01 2005-08-25 Bas Medical, Inc. Methods and systems for enabling and stabilizing tooth movement
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
NZ544050A (en) * 2003-06-11 2009-03-31 Osteotech Inc Osteoimplants and methods for their manufacture
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
ES2282904T3 (en) 2003-09-12 2007-10-16 Wyeth SOLID BARS OF INJECTABLE CALCIUM PHOSPHATE FOR THE SUPPLY OF OSTEOGENIC PROTEINS.
AU2005304435B8 (en) * 2004-11-10 2011-06-23 Tolmar Therapeutics, Inc. A stabilized polymeric delivery system
US20060166251A1 (en) * 2005-01-26 2006-07-27 Archambault Joanne M Use of sFRPs as markers of BMP activity
AU2006230434A1 (en) * 2005-03-30 2006-10-05 Wyeth Methods for stimulating hair growth by administering BMPs
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
US20070184413A1 (en) * 2005-09-28 2007-08-09 Essential Dental Systems, Inc. Pre-coated root canal filling point
WO2007056671A1 (en) 2005-11-02 2007-05-18 Osteotech, Inc. Hemostatic bone graft
US20080102123A1 (en) * 2006-10-27 2008-05-01 Schachter Deborah M Self-gelling tunable drug delivery system
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US8282963B2 (en) * 2007-10-15 2012-10-09 The Regents Of The University Of Colorado, A Body Corporate Methods for extracting platelets and compositions obtained therefrom
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
EP2242476A2 (en) 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2010048610A2 (en) 2008-10-24 2010-04-29 Osteotech, Inc. Compositions and methods for promoting bone formation
JP5819733B2 (en) 2009-02-12 2015-11-24 ストライカー コーポレイションＳｔｒｙｋｅｒ Ｃｏｒｐｏｒａｔｉｏｎ Peripheral administration of TGF-β superfamily member-containing protein for systemic treatment of disorders and diseases
EP2396026A2 (en) 2009-02-12 2011-12-21 Stryker Corporation Compositions and methods for minimally-invasive systemic delivery of proteins including tgf- superfamily members
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
AU2010267528A1 (en) 2009-07-01 2012-02-02 Dexcel Pharma Technologies Ltd. Local therapeutic release device
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
MX359879B (en) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Topical tetracycline compositions.
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
CN102335457A (en) * 2010-07-28 2012-02-01 郭山辉 Composition for tooth regeneration
US8865198B2 (en) 2010-10-25 2014-10-21 Dexcel Pharma Technologies Ltd. Method for treating a periodontal disease
CN103830111A (en) * 2012-11-26 2014-06-04 韩冰 Polylactic acid aquagel and application thereof
JP6564369B2 (en) 2013-12-09 2019-08-21 デュレクト コーポレイション Pharmaceutically active agent conjugates, polymer conjugates, and compositions and methods involving them
CN104939298B (en) * 2015-05-21 2017-11-21 湖南中烟工业有限责任公司 A kind of electronic cigarette Alevaire and electronic cigarette liquid
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
WO2021146215A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
CN113384754B (en) * 2021-08-06 2022-06-28 暨南大学附属第一医院（广州华侨医院） Preparation method of injectable self-healing hydrogel for promoting regeneration of periodontal tissue

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2976251A (en) * 1957-04-19 1961-03-21 Eastman Kodak Co Glycerol fatty acid partial ester gels
US3498957A (en) * 1965-09-14 1970-03-03 Ethicon Inc Polymerization of cyclic carboxylic esters in the presense of a nonpolymerizable ester plasticizer
BE758156R (en) * 1970-05-13 1971-04-28 Ethicon Inc ABSORBABLE SUTURE ELEMENT AND ITS
US4017615A (en) * 1970-10-29 1977-04-12 Syntex Corporation Propylene carbonate ointment vehicle
US3867190A (en) * 1971-10-18 1975-02-18 American Cyanamid Co Reducing capillarity of polyglycolic acid sutures
US3736646A (en) * 1971-10-18 1973-06-05 American Cyanamid Co Method of attaching surgical needles to multifilament polyglycolic acid absorbable sutures
US3978203A (en) * 1974-07-12 1976-08-31 Dynatech Corporation Sustained release of pharmaceuticals from polyester matrices
DE2657370C2 (en) * 1976-12-17 1982-11-11 Hans Dr.med. Dr.med.dent. 8000 München Scheicher Means for covering and / or filling in bone defects
US4474750A (en) * 1976-12-27 1984-10-02 Colgate-Palmolive Company Anticalculus oral composition
US4328204A (en) * 1977-03-02 1982-05-04 Ethicon, Inc. Absorbable polymer-drug compounds and method for making same
US4137921A (en) * 1977-06-24 1979-02-06 Ethicon, Inc. Addition copolymers of lactide and glycolide and method of preparation
US4098885A (en) * 1977-10-14 1978-07-04 Zoecon Corporation Equine anthelmintic
US4175326A (en) * 1977-10-26 1979-11-27 Forsyth Dental Infirmary For Children Hollow-fiber devices for and a method of the treament and diagnosis of oral diseases
US4219548A (en) * 1978-09-01 1980-08-26 The Procter & Gamble Company Topical anti-inflammatory composition
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4454110A (en) * 1982-05-24 1984-06-12 Forsyth Dental Infirmary For Children Self-gelling liquid composition for topical application in the oral cavity
US4568535A (en) * 1982-08-06 1986-02-04 Loesche Walter J Composition for periodontal administration
US4443430A (en) * 1982-11-16 1984-04-17 Ethicon, Inc. Synthetic absorbable hemostatic agent
JPS59222406A (en) * 1983-06-01 1984-12-14 Teijin Ltd Pharmaceutical preparation for remedying periodontosis and its preparation
US4685883A (en) * 1983-09-12 1987-08-11 Jernberg Gary R Local delivery of chemotherapeutic agents for the treatment of periodontal disease
US4892736A (en) * 1983-10-07 1990-01-09 The Forsyth Dental Infirmary For Children Intra-pocket drug delivery devices for treatment of periodontal diseases
US4764377A (en) * 1983-10-07 1988-08-16 The Forsyth Dental Infirmary For Children Intra-pocket drug delivery devices for treatment of periodontal diseases
GR80494B (en) * 1983-10-07 1985-02-04 Forsyth Dental Infirmary Intra-pocket drug delivery devices for treatment of periodontal diseases
JPS60100516A (en) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd Preparation of sustained release microcapsule
US4795436A (en) * 1983-11-14 1989-01-03 Bio-Mimetics, Inc. Bioadhesive composition and method of treatment therewith
AU565354B2 (en) * 1983-11-14 1987-09-10 Bio-Mimetics Inc. Bioadhesive compositions and methods of treatment therewith
US4568536A (en) * 1985-02-08 1986-02-04 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4650665A (en) * 1985-02-08 1987-03-17 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4603076A (en) * 1985-03-04 1986-07-29 Norwood Industries, Inc. Hydrophilic foam
US4670252A (en) * 1985-05-24 1987-06-02 The Procter & Gamble Company Treatment of oral diseases
US4699823A (en) * 1985-08-21 1987-10-13 Kimberly-Clark Corporation Non-layered absorbent insert having Z-directional superabsorbent concentration gradient
US4624256A (en) * 1985-09-11 1986-11-25 Pfizer Hospital Products Group, Inc. Caprolactone polymers for suture coating
US4772484A (en) * 1985-09-24 1988-09-20 Kitchell Judith P Biologically useful polymer preparations
US4692328A (en) * 1985-09-24 1987-09-08 Dynatech Corporation Biologically useful polymer preparations
US5061281A (en) * 1985-12-17 1991-10-29 Allied-Signal Inc. Bioresorbable polymers and implantation devices thereof
JPS62223112A (en) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk Remedy for periodontosis
JPH0759496B2 (en) * 1986-03-25 1995-06-28 ロ−ト製薬株式会社 Periodontal disease treatment agent
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
US4839215A (en) * 1986-06-09 1989-06-13 Ceramed Corporation Biocompatible particles and cloth-like article made therefrom
USRE33093E (en) * 1986-06-16 1989-10-17 Johnson & Johnson Consumer Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
US4731391A (en) * 1986-07-18 1988-03-15 Kimberly-Clark Corporation Process of making a superabsorbent polyurethane foam
US4725628A (en) * 1986-07-18 1988-02-16 Kimberly-Clark Corporation Process of making a crosslinked superabsorbent polyurethane foam
US4725629A (en) * 1986-07-18 1988-02-16 Kimberly-Clark Corporation Process of making an interpenetrating superabsorbent polyurethane foam
US4769414A (en) * 1986-09-08 1988-09-06 Grain Processing Corporation Absorbent compositions
JPH0617300B2 (en) * 1986-09-22 1994-03-09 サンスタ−株式会社 Composition for treating periodontal disease
DE3635679A1 (en) * 1986-10-21 1988-05-05 Dynamit Nobel Ag Surgical suture material
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
JPH0744940B2 (en) * 1986-12-24 1995-05-17 ライオン株式会社 Base material for oral application
US4788062A (en) * 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
DE3708916A1 (en) * 1987-03-19 1988-09-29 Boehringer Ingelheim Kg METHOD FOR CLEANING RESORBABLE POLYESTERS
US4818534A (en) * 1987-04-01 1989-04-04 Lee County Mosquito Control District Insecticidal delivery compositions and methods for controlling a population of insects in an aquatic environment
JPH0645535B2 (en) * 1987-05-20 1994-06-15 サンスタ−株式会社 Composition for treating alveolar bone metabolism
US4920203A (en) * 1987-12-17 1990-04-24 Allied-Signal Inc. Medical devices fabricated from homopolymers and copolymers having recurring carbonate units
US4900552A (en) * 1988-03-30 1990-02-13 Watson Laboratories, Inc. Mucoadhesive buccal dosage forms
US4969884A (en) * 1988-12-28 1990-11-13 Alza Corporation Osmotically driven syringe
US5143934A (en) * 1990-11-21 1992-09-01 A/S Dumex (Dumex Ltd.) Method and composition for controlled delivery of biologically active agents
US5198220A (en) * 1989-11-17 1993-03-30 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5084267A (en) * 1989-11-17 1992-01-28 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5030216A (en) * 1989-12-15 1991-07-09 Alza Corporation Osmotically driven syringe
US5200195A (en) * 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
US5242910A (en) * 1992-10-13 1993-09-07 The Procter & Gamble Company Sustained release compositions for treating periodontal disease

Also Published As

Publication number Publication date
EP0702567A1 (en) 1996-03-27
US5447725A (en) 1995-09-05
CA2164933C (en) 1999-01-12
WO1994028935A1 (en) 1994-12-22
JPH08511528A (en) 1996-12-03
CN1126948A (en) 1996-07-17

Similar Documents

Publication Publication Date Title
CA2164933A1 (en) Methods for Aiding Periodontal Tissue Regeneration
CA2004598A1 (en) Medicinal aerosol formulations
CA2213700A1 (en) Pharmaceutical composition for piperidinoalkanol compounds
CA2172616A1 (en) Tropyl 7-azaindol-3-ylcarboxyamides as antitussive agent
MTP1012B (en) New pharmacologically active compounds,methods for the preperation thereof and compositions containing the same
WO1997012583A3 (en) Stable compositions containing n-propargyl-1-aminoindan
CA2342340A1 (en) New sustained release oral formulations
CA2358773A1 (en) Improved controlled release compositions and method
CA2315767A1 (en) Autoclavable pharmaceutical compositions containing a chelating agent
PT90556A (en) Process for the preparation of a granular detergent composition for washing containing an anionic active agent
AU6866291A (en) Pharmacologically active compounds and mixtures thereof, organic compositions and metal salts
CA2271196A1 (en) Pharmaceutical compositions of hiv protease inhibitors with improved oral bioavailability
EP0812874A4 (en) Easy-to-break-through film
CA2163837A1 (en) Crystalline Paclitaxel Hydrates
CA2136331A1 (en) New pharmaceutical uses of krill enzymes
CA2011452A1 (en) Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7–,17–)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn -3-one
EP0968712A4 (en) Felbinac-containing patch
JP2001513504A5 (en)
HUP0004223A3 (en) 4-oxo-butynic acids and pharmaceutical composition containing them as active agent
CA2185242A1 (en) Sustained release tablet containing diclofenac-na
IL93317A0 (en) Cell antiproliferation factor containing suppressin,processes for the preparation thereof and pharmaceutical compositions containing the same
CA2021631A1 (en) Noncontaminating antimicrobial composition
EP0378413A3 (en) Compositions for topical treatment of skin disorders
CA2192822A1 (en) Use of immunosuppressive agents for the treatment of schizophrenia
FR2695297B1 (en) Disinfectant agent composition.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed